Preventive Physical Activity Intervention in Head and Neck Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSahlgrenska University Hospital

About this trial

The study includes patients with tumors of the oropharynx, larynx and hypopharynx scheduled to receive radiotherapy with curative intent (+/- chemotherapy). The patients will be randomized into either an intervention group (performing a preventive physical activity protocol before and during radiotherapy) or a control group not performing a specified physical exercise protocol. All patients will be in contact with with a speech language pathologist or a physical therapist weekly during radiotherapy. The study is expected to improve physical function and quality of life during and after oncologic treatment

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Head and neck cancer (tumors of the oropharynx, pharynx, hypopharynx and larynx)

Receiving radiohterapy (+/- chemotherapy) with curative intent

Disqualifiers

Surgery due to head and neck cancer

Previous treatment for head and neck cancer

Tracheostomized patients

Inability to perform exercise intervention

Trial design

Design model

Parallel

Treatments tested in this trial

  • Preventive physical exercise

    Behavioral

    Daily physical activity depending on daily condition

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Physical exercise interventionExperimental treatment 1 intervention
Group B: ControlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Objectively measured physical activity

Measured with an accelerometer. Measures time spent in different activities i minutes/day.

Time frame
Up to 12 months
2

Subjectively measured physical activity - Saltin-Grimby

Measured with the Saltin-Grimby physical activity level scale and the International Physical Activity Questionnaire.

Time frame
Up to 12 months
3

Subjectively measured physical activity (IPAQ)

Measured with the International Physical Activity Questionnaire

Time frame
Up to 12 months

Secondary outcomes

1

Health related quality of life (HRQL) using the EORTC QLQ-C30

Measured with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) core questionnaire (c30). Consists of 30 items divided into six functional domains (Physical, Role, Cognitive, Emotional, and Social Functioning and Global Quality of life), three symptom scales (Fatigue, Pain, and Nausea/Vomiting) and six single items (Constipation, Diarrhea, Insomnia, Dyspnea, Appetite Loss, and Financial Difficulties). All domains range from 0-100. For the functional domains a higher score indicates good function, while for all other domains a high score indicates a high prevalence of symtoms, i.e. worse HRQL.

Time frame
Up to 5 years post radiotherapy
2

Health related quality of life (HRQL) using the EORTC QLQ H&N35

Measured with the EORTC QLQ Head and neck module (HN35). It consists of 35 questions regarding symptoms more specific to the head and neck cancer population, and domain scores range from 0-100, where a higher score represents the prevalence of more symtoms, i.e. worse HRQL.

Time frame
Up to 5 years post radiotherapy
3

Trismus and jaw related symptoms

Patient Reported Outcomes (PRO) measured with Gothenburg Trismus Questionnaire (GTQ). The GTQ consists of 21 items divided into 3 domains; Jaw related problems, Eating limitations and Muscular tension and eight single items concerning facial pain, limitations in mouth opening and inabilities to function on social and working contexts. The GTQ domains range from 0-100 where 0 equals to absence of symtoms and 100 equals worst possible symptoms.

Time frame
Up to 5 years post radiotherapy
4

Dysphagia related symtoms

PRO measured with M.D Anderson Dysphagia Inventory (MDADI). This is a cancer-specific instrument measuring dysphagia, social function and quality of life in head and neck cancer patients. It consists of 19 items in four domains; emotional, physical, functional and global quality of life. The range for each subscale is 20-100 where 100 indicates best possible swallowing, i.e. better outcome.

Time frame
Up to 5 years post radiotherapy

Other outcomes

1

Cost

The cost of intervention compared to usual care. Costs in Swedish crowns (SEK) for the intervention and all visits to healthcare during 5 years will be recorded.

Time frame
Up to 5 years post radiotherapy
2

Quality of life for cost-effectiveness analysis

The outcomes of intervention compared to usual care using European Quality of life 5 dimensions (EQ5D).

Time frame
Up to 5 years post radiotherapy
3

Quality Adjusted Life Years (QALY)

QALY is a measurement that combines health-related quality of life (HRQL) and life expectancy in one index. The index range between 0 and 1, where 0 equals death and 1 represents perfect health. Thus, 1 QALY corresponds to 1 year of perfect health. This is calculated using the EQ-5D.

Time frame
Up to 5 years post radiotherapy
4

Incremental Cost Effectiveness Ratio (ICER)

Incremental cost for each QALY for the intervention group will be calculated using a Markov model which combines the costs and EQ-5D. The ICER will then be compared to the maximum willingness to pay level which is SEK 500,000 (€55,000) according to the Swedish National Board of Health and Welfare.

Time frame
Up to 5 years post radiotherapy

Sponsors and contacts

Click on the lead sponsor to view all of their trials.